A new study reveals that antimicrobial resistance is rising worldwide - eroding the effectiveness of last-line antibiotics ...

FVR is a serious feline respiratory disease with high mortality, especially in untreated kittens, and a seroprevalence of 50-97%. Famciclovir, effective against FVR, was studied in cats to determine ...

OV350 showed a good safety profile, supporting the advancement of the Company’s KCC2 portfolio, including the first oral direct activator, OV4071There were no treatment-related laboratory findings, no ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) ('Artelo” or the 'Company”), a clinical-stage pharmaceutical company focused on ...

Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety ...

Reviva Pharmaceuticals said the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine after a ...

Gilead agreed to acquire Repare's RP-3467 cancer drug for up to $30 million, boosting Repare's cash and expected shareholder payout.

Simulations Plus, Inc. (NASDAQ:SLP) is one of the best healthcare AI stocks to buy now. On December 9, Simulations Plus, Inc.

LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company developing first-in-class, orally delivered immune-tolerance-restoring therapies, announced today that the first patient ...

Mondego Bio selects PTPN2 inhibitor clinical candidate and targets first-in-human trials in H1 2026: Cantanhede, Portugal Tuesday, December 23, 2025, 17:00 Hrs [IST] Mondego Bio, ...